This is a girl with adolescent idiopathic scoliosis (left) and posterior-anterior standing x-ray of spine (right).
Their study is published today in the journal Nature Genetics.
AIS is the most common pediatric skeletal disease, affecting approximately 2% of school-age children. The causes of scoliosis remain largely unknown and brace treatment and surgery are the only treatment options. However, many clinical and genetic studies suggest a contribution of genetic factors.
To understand the causes and development of scoliosis, Dr Ikuyo Kou, Dr Shiro Ikegawa and their team have tried to identify genes that are associated with a susceptibility to develop the condition.
By studying the genome of 1,819 Japanese individuals suffering from scoliosis and comparing it to 25,939 Japanese individuals, the team identified a gene associated with a susceptibility to develop scoliosis on chromosome 6. The association was replicated in Han Chinese and Caucasian populations.
The researchers show that the susceptibility gene, GPR126, is highly expressed in cartilage and that suppression of this gene leads to delayed growth and bone tissue formation in the developing spine. GPR126 is also known to play a role in human height and trunk length.
"Our finding suggest the interesting possibility that GPR126 may affect both AIS susceptibility and height through abnormal spinal development and growth," explain the authors."Further functional studies are necessary to elucidate how alterations in GPR126 increase the risk of AIS in humans," they conclude.
"Genetic variants in GPR126 are associated with adolescent idiopathic scoliosis." Kou et al. Nature Genetics 2013, DOI: 10.1038/ng.2639
RIKEN is Japan's flagship research institute devoted to basic and applied research. Over 2500 papers by RIKEN researchers are published every year in reputable scientific and technical journals, covering topics ranging across a broad spectrum of disciplines including physics, chemistry, biology, medical science and engineering. RIKEN's advanced research environment and strong emphasis on interdisciplinary collaboration has earned itself an unparalleled reputation for scientific excellence in Japan and around the world.
About the Center for Integrative Medical Sciences
The Center for Integrative Medical Sciences, based in Yokohama, aims to develop revolutionary medical therapies based on collaborative projects between researchers from different areas of science. By achieving a deeper understanding of homeostasis, and how the breakdown of homeostasis leads to disease, scientists at IMS are working to develop personalized preventive medicine and personalized medicine that can allow us to lead healthier lives. The centers focuses include genomics, immunology, allergies, inflammation, endocrinology, and the new field of metabolomics.
Juliette Savin | EurekAlert!
Faster fish thanks to nMLF neurons
25.07.2014 | Max Planck Institute of Neurobiology, Martinsried
A glimpse into the genetic basis of schizophrenia
25.07.2014 | Max Planck Institute of Psychiatry, München
24.07.2014 | Event News
08.07.2014 | Event News
08.07.2014 | Event News
25.07.2014 | Earth Sciences
25.07.2014 | Materials Sciences
25.07.2014 | Physics and Astronomy